Observational studyAlimentary pharmacology & therapeutics2026

Real-World Effectiveness of Risankizumab in Refractory Crohn's Disease: The RISANCROHN Study From the ENEIDA Registry.

Manuel Barreiro-de Acosta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.